Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of the likelihood of hypothyroidism in dogs diagnosed with and treated for hypothyroidism at primary care practices: 102 cases (2016-2021).
Travail V, Fernandez Sanchez C, Costo JM, Valentine N, Conroy M, Lee V, Bouziopoulos D, Bateman K, Gatehouse E, Cruzado-Perez J, Pollard D, Lamb V, Juvet F, Kelly D. Travail V, et al. Among authors: bateman k. J Vet Intern Med. 2024 Mar-Apr;38(2):931-941. doi: 10.1111/jvim.16993. Epub 2024 Feb 5. J Vet Intern Med. 2024. PMID: 38314891 Free PMC article.
A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques.
Wu HL, Weber WC, Waytashek CM, Boyle CD, Reed JS, Bateman KB, Fisher HK, Chen Y, Armantrout K, Swanson T, Shriver-Munsch C, Northrup M, Fischer M, Biswas S, Templon J, Panoskaltsis-Mortari A, Burwitz BJ, Johnson AL, Colgin L, Lewis AD, Smedley JV, Axthelm MK, Skalsky R, Meyers G, Maziarz RT, Mittra E, Berg M, Stanton JJ, Sacha JB. Wu HL, et al. Among authors: bateman kb. PLoS Pathog. 2024 Nov 11;20(11):e1012644. doi: 10.1371/journal.ppat.1012644. eCollection 2024 Nov. PLoS Pathog. 2024. PMID: 39527641 Free PMC article.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
353 results